ArticleThoracic cancer2020

First-line immune checkpoint therapy in metastatic squamous cell lung cancer harboring both EGFR mutation and high expression of PD-L1: A case report.

Kosuke Hamai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.